Condition
Skin Ulcer Venous Stasis Chronic
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (2)
P 2 (1)
Trial Status
Terminated2
Completed2
Withdrawn1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04971161Phase 2CompletedPrimary
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
NCT02307448Not ApplicableTerminated
Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds
NCT03257098Phase 1CompletedPrimary
Allogeneic ABCB5-positive Stem Cells for Treatment of CVU
NCT02742844Phase 1TerminatedPrimary
Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From Ulcers
NCT01913704Not ApplicableWithdrawnPrimary
Pilot Study Comparing NatroxTM Topical Oxygen Therapy to A Placebo in the Management of Non-Healing Leg Ulcers
Showing all 5 trials